JAMCO Corporation
JAMCO Corporation (JMCCF) Financial Performance & Income Statement Overview
Analyze JAMCO Corporation (JMCCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
JAMCO Corporation (JMCCF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for JAMCO Corporation JMCCF financial performance.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $23.41B | $19.09B | $20.05B | $16.43B |
| Cost of Revenue | $17.54B | $13.77B | $15.96B | $13.06B |
| Gross Profit | $5.87B | $5.32B | $4.09B | $3.37B |
| Gross Profit Ratio | $0.25 | $0.28 | $0.20 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.13B | $2.67B | $2.78B | $2.66B |
| Operating Expenses | $3.13B | $2.67B | $2.78B | $2.66B |
| Total Costs & Expenses | $20.67B | $16.45B | $18.74B | $15.73B |
| Interest Income | $16.42M | $22.11M | $27.31M | $22.09M |
| Interest Expense | $446.02M | $452.35M | $473.40M | $449.37M |
| Depreciation & Amortization | $542.42M | $444.25M | $513.00M | $502.54M |
| EBITDA | $3.23B | $3.09B | $1.83B | $1.41B |
| EBITDA Ratio | $0.14 | $0.16 | $0.09 | $0.09 |
| Operating Income | $2.74B | $2.65B | $1.32B | $707.69M |
| Operating Income Ratio | $0.12 | $0.14 | $0.07 | $0.04 |
| Other Income/Expenses (Net) | -$72.65M | -$344.00M | -$653.00M | -$244.71M |
| Income Before Tax | $2.67B | $2.31B | $663.00M | $462.97M |
| Income Before Tax Ratio | $0.11 | $0.12 | $0.03 | $0.03 |
| Income Tax Expense | $899.99M | $719.00M | -$9.23M | $203.94M |
| Net Income | $1.77B | $1.59B | $672.00M | $259.03M |
| Net Income Ratio | $0.08 | $0.08 | $0.03 | $0.02 |
| EPS | $65.87 | $59.06 | $25.03 | $9.65 |
| Diluted EPS | $65.87 | $59.06 | $25.03 | $9.65 |
| Weighted Avg Shares Outstanding | $26.86M | $26.86M | $26.85M | $26.84M |
| Weighted Avg Shares Outstanding (Diluted) | $26.86M | $26.86M | $26.85M | $26.84M |
The company's financials show resilient growth, with revenue advancing from $16.43B in Q1 2025 to $23.41B in Q4 2025. Gross profit remained healthy with margins at 25% in Q4 2025 compared to 21% in Q1 2025. Operating income hit $2.74B last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.23B. Net income rose to $1.77B, while earnings per share reached $65.87. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan